Zobrazeno 1 - 10
of 20
pro vyhledávání: '"CVD Regimen"'
Publikováno v:
Medicine. 99:e22811
Rationale Carotid body tumors (CBTs) are head and neck paragangliomas (PGLs) with a low incidence of distant metastasis. To date, only a few metastatic cases treated with detailed systemic therapy are reported and effective management is still inconc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b12ec53c5a2d0aed52b93ae5358cb18b
https://doi.org/10.1097/md.0000000000022811
https://doi.org/10.1097/md.0000000000022811
Publikováno v:
Hospital Pharmacy. 47:518-523
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86e127bb0957421f65c8c87065ee3693
https://doi.org/10.1310/hpj4707-518
https://doi.org/10.1310/hpj4707-518
Autor:
Timo Deutschbein, Martin Fassnacht, Martin Reincke, Dirk Weismann, Klaus Mann, Stephan Petersenn
Publikováno v:
Clinical endocrinology. 82(1)
SummaryObjective Malignant phaeochromocytomas are rare and highly aggressive tumours. This retrospective study evaluated the outcome of combined chemotherapy with cyclophosphamide, vincristine and dacarbazine (also known as CVD regimen). Methods Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2108de9133045b94d8f5dee53a3765e1
https://pubmed.ncbi.nlm.nih.gov/25143180
https://pubmed.ncbi.nlm.nih.gov/25143180
Autor:
Rebecca Garris, Hagop M. Kantarjian, Elias Jabbour, Marina Konopleva, Deborah A. Thomas, Jorge E. Cortes, Nitin Jain, Farhad Ravandi, Jovitta Jacob, Susan O'Brien, Yogin B Patel, Guillermo Garcia-Manero, Koji Sasaki, Kelsey N Voit, Maro Ohanian, Gautam Borthakur
Publikováno v:
Blood. 128:5194-5194
Background: The mini-hyper-CVD regimen is being developed as a frontline treatment for older (≥60 years) patients with acute lymphoblastic leukemia (ALL). This regimen utilizes reduced doses of conventional cytotoxic chemotherapy in comparison to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f6502eca59b3306280d12f1443927fa
https://doi.org/10.1182/blood.v128.22.5194.5194
https://doi.org/10.1182/blood.v128.22.5194.5194
Autor:
Robert S. Benjamin, Elizabeth A. Grimm, Agop Y. Bedikian, Carl Plager, Francis Ali-Osman, Omar Eton, Sigrid Ring, Antonio C. Buzaid, Nicholas E. Papadopoulos, Sewa S. Legha
Publikováno v:
Melanoma Research. 4:327-330
During the conduct of a biochemotherapy trial in which cisplatin, vinblastine and dacarbazine (CVD) were administered concurrently with interleukin-2 (IL-2) plus interferon-alpha 2a (IFN-alpha 2a) (biochemotherapy) in advanced melanoma, we performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::883dfb96963a28f74a922b76893bec17
https://doi.org/10.1097/00008390-199410000-00010
https://doi.org/10.1097/00008390-199410000-00010
Autor:
Shingo Hosoi, Tetsuhiro Minamikawa, Hiroki Watanabe, Osamu Ukimura, Hideaki Itoh, Munekado Kojima
Publikováno v:
The Japanese Journal of Urology. 85:811-814
A 44-year-old male had multiple metastasis to the lung, liver, kidney and paraaortic lymph node from primary adrenal malignant pheochromocytoma. Radiation therapy with 131I-metaiodobenzylguanidine (131I-MIBG), was first performed, which was followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99cb00223a9860c7575ea50b9a73a33a
https://doi.org/10.5980/jpnjurol1989.85.811
https://doi.org/10.5980/jpnjurol1989.85.811
Once metastatic, melanoma remains one of the most aggressive and morbid malignancies. Moreover, in past decades, the overall survival for advanced unresectable melanoma exhibited a constancy of poor prognosis. Low response rates and serious adverse e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc11baaadb568a921c187de5ff0589a0
https://europepmc.org/articles/PMC3685319/
https://europepmc.org/articles/PMC3685319/
TREATMENT OF MALIGNANT PHEOCHROMOCYTOMA BY COMBINATION OF CVD REGIMEN AND TRANSARTERIAL EMBOLIZATION
Autor:
Yasushi Katayama, Toshiki Tsutsui, Ikuo Odano, Yoshiaki Kawakami, Akiyoshi Katagiri, Shotaro Sato, Toshio Kanai, Takeshi Komeyama, Masayuki Takeda, Motomasa Kimura
Publikováno v:
The Japanese Journal of Urology. 82:826-829
We performed combination therapy with cyclophosphamide, Vincristine and Dacarbazine (CVD) regimen and transarterial embolization (TAE) in 2 cases of malignant pheochromocytoma with metastases. Case 1: 59-year-old female. After primary left adrenal le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f825286825768cc896960e8d43ed00bf
https://doi.org/10.5980/jpnjurol1989.82.826
https://doi.org/10.5980/jpnjurol1989.82.826
Autor:
Alberto Fusi, Emilio Bajetta, Mario Roberto Sertoli, Barbara Formisano, Paola Taveggia, M. Del Vecchio, P. Nova, S. S. Legha, A. Daponte, Paola Queirolo, Natale Cascinelli, Maria Grazia Bernengo
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17(4)
Background: The addition of cytokines to chemotherapy (CT) has obtained encouraging but contradictory results in metastatic melanoma. In this phase III trial, we compared the effects of CT [cisplatin, vindesine and dacarbazine (CVD)] with those of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e8e6cccf6badd7b31f130acfb381be
https://pubmed.ncbi.nlm.nih.gov/16469753
https://pubmed.ncbi.nlm.nih.gov/16469753
Autor:
Carol J. Whelan, Darren Foard, Shameem Mahmood, Philip N. Hawkins, Lisa Rannigan, Christopher P. Venner, Simon D. J. Gibbs, Helen J. Lachmann, Julian D. Gillmore, Sanjay M Banypersad, Thirusha Lane, Jason Dungu, Jennifer H. Pinney, Ashutosh D. Wechalekar
Publikováno v:
Blood. 120:2966-2966
Abstract 2966 Introduction: Poor survival in AL amyloidosis is largely driven by outcomes in patients with advanced cardiac disease. To date, the Mayo cardiac staging system is the most widely used tool to identify these high risk patients. For stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::adacdc28233ebbfac9490ff0a4b86ee6
https://doi.org/10.1182/blood.v120.21.2966.2966
https://doi.org/10.1182/blood.v120.21.2966.2966